Author:
Maughan T.S.,Fish R.G.,Shelley M.,Jasani B.,Williams G.T.,Adams M.
Reference15 articles.
1. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer;Bast;N. Engl. J. Med.,1983
2. Ovarian cancer antigen CA125: A prospective clinical assessment of its role as a tumour marker;Canney;Brit. J. Cancer,1984
3. Monitoring CA125 serum levels to predict treatment outcome in ovarian cancer patients;Colombo,1985
4. Radioimmunoassay of the CA125 antigen in ovarian carcinomas: Advantages compared to CA19-9 and CEA;Ricolleau;Tumour Biol.,1984
5. The clinical value of serum CA125 levels in ovarian cancer patients receiving Cisplatin or Carboplatin infusion therapy;Fish;Eur. J. Cancer Clin. Oncol.,1987